SCHEDULE: Valiant Capital Management Discloses Core Scientific Stake

Valiant Capital Management, L.P., Valiant Capital Management, LLC, and Christopher R. Hansen have jointly filed a Schedule 13G, reporting beneficial ownership of 5.3% of Core Scientific, Inc. common stock as of June 30, 2026.

Summary

• Valiant Capital Management, L.P. (VCM), Valiant Capital Management, LLC (VCM LLC), and Christopher R. Hansen have filed an amended Schedule 13G, reporting their beneficial ownership of Core Scientific, Inc. common stock.
• The filing indicates a shared voting and dispositive power over 16,956,009 shares, representing 5.3% of the class of securities.
• This ownership percentage is calculated based on 321,340,441 shares of Common Stock outstanding as of July 23, 2026, as reported in Core Scientific's Form 10-Q for the quarter ended June 30, 2026.
• VCM acts as the investment adviser and general partner for private investment funds that hold the shares.
• VCM LLC is the general partner of VCM, and Mr. Hansen is identified as the control person of both VCM and VCM LLC.
• The reporting persons have entered into a joint filing agreement.
• Each reporting person disclaims beneficial ownership except to the extent of their pecuniary interest and states they are not acting as a group.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, as it primarily reports a passive investment stake without significant new strategic information or performance indicators.

Positives

• The filing clearly delineates the ownership structure and reporting responsibilities among Valiant Capital Management entities and Christopher R. Hansen.
• The joint filing agreement ensures coordinated reporting for regulatory compliance.

Negatives

• The filing does not provide any new operational or financial performance data for Core Scientific, Inc., focusing solely on ownership disclosure.
• The passive nature of the investment, as indicated by the lack of intent to influence control, suggests no immediate strategic catalyst from this filing.

Risks

• The filing does not explicitly mention any risks associated with the investment or the company's operations.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Core Scientific, Inc.'s future performance. It solely reports on the beneficial ownership of securities.

Management Comments

• Each reporting person disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein.
• Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein and states they are not acting as a group.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors accumulating significant stakes in public companies. This filing indicates Valiant Capital Management's substantial, yet passive, investment in Core Scientific, Inc., a company operating in the digital asset mining sector.

Comparison to Industry Standards

• The filing does not provide performance data or operational metrics that would allow for comparison to industry standards or specific companies.

Stakeholder Impact

• Shareholders: The filing confirms a significant passive stake held by Valiant Capital Management, which could be a factor in market perception but does not indicate immediate changes in corporate control or strategy.
• Creditors: No direct impact is indicated, as the filing focuses on equity ownership.
• Employees: No direct impact is indicated by this ownership disclosure.

Next Steps

• Continued monitoring of Core Scientific, Inc.'s operational and financial performance by Valiant Capital Management.
• Potential future amendments to the Schedule 13G filing if ownership levels or intentions change.

Key Dates

Keywords

Core Scientific, Valiant Capital Management, Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, Christopher Hansen